Safety and efficacy evaluation of long-course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer: Intermediate results of a multicenter, phase II study

被引：0
|
作者：
Yang, Z. [1 ]
Gao, J. [1 ]
Zhang, X. [1 ]
Wu, G. [1 ]
Deng, W. [1 ]
Liu, Y. [1 ]
Zhang, J. [2 ]
Chen, G. [3 ]
Xu, R. [3 ]
Han, J. [4 ]
Li, A. [5 ]
Liu, G. [6 ]
Sun, Y. [7 ]
Kong, D. [8 ]
Bai, Z. [1 ]
Yao, H. [1 ]
Zhang, Z. [1 ]
机构：
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Friendship Hosp, Dept Pathol, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Chaoyang Hosp, Dept Gen Surg, Beijing, Peoples R China
[5] Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China
[6] Tianjin Med Univ Gen Hosp, Dept Gen Surg, Tianjin, Peoples R China
[7] Tianjin Peoples Hosp, Dept Anorectal, Tianjin, Peoples R China
[8] TMUCIH, Dept Colorectal Canc, Tianjin, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.079
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
47P
引用
收藏
页码：S1447 / S1447
页数：1
相关论文
共 50 条
  • [11] Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience
    Tseng, Michelle Shu Fen
    Zheng, Huili
    Ng, Ivy Wei Shan
    Leong, Yiat Horng
    Leong, Cheng Nang
    Yong, Wei Peng
    Cheong, Wai Kit
    Tey, Jeremy Chee Seong
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (06) : 305 - 310
  • [12] Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
    Sapienza, Lucas G.
    Raychaudhuri, Sreejata
    Nahlawi, Suraya K.
    Ozeir, Serene
    Abu-Isa, Eyad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [13] Neoadjuvant short-course radiotherapy followed by camrelizumab plus chemotherapy versus long-course chemoradiotherapy followed by chemotherapy in locally advanced rectal cancer: A randomized phase III trial (UNION)
    Zhang, T.
    Tao, K.
    Lin, Z.
    Zhang, P.
    Yin, Y.
    Chi, P.
    Huang, Y.
    Xiao, Y.
    Sun, Z.
    Xu, X.
    Zhang, A.
    Qiu, X.
    Junxin, W.
    Yuan, Y.
    Wang, Z.
    Qu, X. J.
    Zhao, F.
    Ma, C.
    Cheng, F.
    Hou, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S1266 - S1267
  • [14] Timing of Surgery after Neoadjuvant Long-course Chemoradiotherapy in the Management of Locally Advanced Rectal Cancer
    Panagiotopoulou, I. G.
    Parashar, D.
    Mezher-Sikafi, R.
    Parmar, J.
    Wells, A. D.
    Menon, M.
    Jephcott, C. R.
    CLINICAL ONCOLOGY, 2012, 24 (10) : E195 - E195
  • [15] Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
    Fang He
    Mo Chen
    Yan-ping Liu
    Jiachun Sun
    Jian Zheng
    Discover Oncology, 13
  • [16] Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)
    Wang, Jingwen
    Guan, Yun
    Gu, Weilie
    Yan, Senxiang
    Zhou, Juying
    Huang, Dan
    Tong, Tong
    Li, Chao
    Cai, Sanjun
    Zhang, Zhen
    Zhu, Ji
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [17] Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
    He, Fang
    Chen, Mo
    Liu, Yan-Ping
    Sun, Jiachun
    Zheng, Jian
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [18] Risk factors and treatment strategies for local recurrence of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by total mesorectal excision
    Kim, Seijong
    Huh, Jung Wook
    Lee, Woo Yong
    Yun, Seong Hyeon
    Kim, Hee Cheol
    Cho, Yong Beom
    Park, Yoonah
    Shin, Jung Kyong
    EJSO, 2024, 50 (11):
  • [19] Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)
    Jingwen Wang
    Yun Guan
    Weilie Gu
    Senxiang Yan
    Juying Zhou
    Dan Huang
    Tong Tong
    Chao Li
    Sanjun Cai
    Zhen Zhang
    Ji Zhu
    Radiation Oncology, 14
  • [20] Efficacy and safety of neoadjuvant chemoradiotherapy combined with tislelizumab and thymalfasin in the treatment of locally advanced lower rectal cancer
    Yao, Hongwei
    Gao, Jiale
    Yang, Zhengyang
    Sun, Liting
    Wei, Pengyu
    Wu, Si
    Meng, Cong
    Xu, Rui
    Chen, Guangyong
    Wu, Guocong
    Bai, Zhigang
    Zhang, Zhongtao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345